https://www.live-feeds.com/feed/the-company-behind-a-new-glp-1-pill-is-betting-6-5-billion-on-houstonContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/the-company-behind-a-new-glp-1-pill-is-betting-6-5-billion-on-houstonhttps://www.live-feeds.com/feed/the-company-behind-a-new-glp-1-pill-is-betting-6-5-billion-on-houston#u83132Fri, 25 Sep 2026 00:06:12 +0000Eli Lilly has broken ground on a $6.5 billion manufacturing plant in Houston's Generation Park, scheduled for completion by 2030. CEO Dave Ricks reported that the company's GLP-1 pill, Foundayo, now captures one-third of new patients starting that medication. Lilly is also seeing significant growth among seniors, with Ricks stating 70% of the 700,000 new Medicare patients starting GLP-1s are using Lilly products. The company is simultaneously ramping up production and targeting foreign markets to expand Foundayo's reach.Why it mattersThis expansion is part of a larger domestic s